ESMO National Representative in United Kingdom
|Term||2012 – 2014|
Academic Unit of Clinical Oncology, Weston Park Hospital
Sheffield Cancer Research Centre
Professor Coleman graduated from Kings College Hospital Medical School, University of London in 1978. Following clinical training in oncology in London and Edinburgh and completion of a research doctorate (MD) in the field of bone metastases, he became senior lecturer and honorary consultant in the newly formed Academic Unit of Clinical Oncology at Weston Park Hospital in 1991.
Following subsequent promotions to Reader in 1996 and Professor in 1999, he now leads a large clinical research team and is the director of the Sheffiels Cancer Research Centre. Between 2011 and 2013, he was an associate director of the National Cancer Research Network (NCRN). He was Chairman of the National Cancer Research Institute Breast Cancer Study Group in the UK (2004-09) and Past-President of the Cancer and Bone Society (2005-08). His clinical expertise includes breast cancer, gestational trophoblastic disease and cancer induced bone disease. Since 2014 he has been a part time medical director for Prime Oncology, an independent international provider of medical education in oncology.
Over the years, Robert Coleman has developed a highly successful cancer clinical trials facility, which has both led and participated in a broad range of clinical trials. These have ranged from early phase drug development studies to large phase III randomised trials. As research lead for clinical cancer research, he is responsible for developing the Cancer Clinical Trials Centre, a purpose built clinical research facility that provides research infrastructure to support the Yorkshire and Humber Cancer Research Network, the Experimental Cancer Medicine Centre, and the breast cancer component of the bone oncology research laboratories within the medical school.
Rob is passionate about improving the care of cancer patients through research and has particular interests in cancer-induced bone disease and developments in the management of breast cancer. He has authored or co-authored more than 350 publications of original research. He is the founding author of Journal of Bone Oncology and is on the editorial board of several oncology journals including European Journal of Cancer, The Breast and Cancer Treatment Reviews.
Professor Coleman is the ESMO National Representative for the United Kingdom, a member of the ESMO Membership Steering Committee and is on the ESMO Faculty for Breast Cancer.